Company Overview and News

 
Sensex snaps 5-day losing streak; SBI lifts PSU Bank 3%; Bajaj Fin at record close

23h moneycontrol
Bulls managed to get charge at Dalal Street on Tuesday as benchmark indices ended in the green for the first time in last six consecutive sessions, backed by short covering in most beaten down stocks. Investors closely watch corporate earnings, and the movement in crude oil prices and rupee.

 
Closing Bell: Sensex, Nifty end mildly higher; SBI, DRL top gainers

2018-05-22 moneycontrol
Market Closing: Benchmark indices snapped five-day losing streak, led by short covering most beaten down stocks like banks.

 
Market Update: SBI top gainer on Nifty, up 3% despite poor Q4; PC Jeweller zooms 16%

2018-05-22 moneycontrol
The market continues to trade on a positive note on Tuesday afternoon, with the Nifty up 11 points at 10,523 and the Sensex up 30 points at 34,646.

 
Market Live: Sensex consolidates; SBI shares rise despite posting big Q4 loss, Tata Motors top gainer

2018-05-22 moneycontrol
Market Update: The market continued to be rangebound as investors closely monitor earnings season, and the movement in oil prices and rupee.

 
Market Update: 154 stocks hit new 52-week lows; RCom, JP Associates jump 4-8%

2018-05-22 moneycontrol
The market was trading on a negative note on Tuesday morning, with the Nifty down 19 points at 10,496 and the Sensex down 51 points at 34,569.

 
Nifty corrects for 5th day, Sensex sheds 232 pts; Nifty Midcap dives 321 pts amid weak earnings

2018-05-21 moneycontrol
The market extended losses for fifth consecutive session on Monday despite positive global cues, as the Sensex fell more than 200 points amid weak midcap companies' earnings. Higher crude oil prices and weaker rupee also dented sentiment.

 
Closing Bell: Sensex corrects 232 pts, Nifty Midcap sheds 321 pts amid Q4 earnings

2018-05-21 moneycontrol
Market Update: Benchmark indices ended lower for the fourth consecutive session, dragged by pharma, metals, auto stocks, HDFC twins and Reliance Industries.

 
Market Live: Nifty at day#39;s low, Sensex falls 200 pts; Colgate, TTK Prestige dip 4% post Q4 nos

2018-05-21 moneycontrol
Acquisition: Infibeam Incorporation said Infibeam Global EMEAFZ-LLC, the wholly owned subsidiary based in Dubai has acquired 100 percent shareholding of Vavian International Limited, a company formed and registered in Dubai.

 
Market Live: Midcap underperforms Sensex; Bajaj Finance corrects after 2-day gains

2018-05-21 moneycontrol
Earnings: Kitchen appliances maker TTK Prestige has reported a 32.4 percent decline year-on-year in profit at Rs 37.4 crore for the January-March quarter against Rs 55.3 crore in same period last year.

 
Market Live: Sensex falls 200 pts, Midcap underperforms; Avenue Supermarts dips further

2018-05-21 moneycontrol
Buzzing: Shares of Dilip Buildcon fell 5.6 percent intraday as company's promoters pledged their shares with RBL Bank.

 
Market Live: Nifty struggles below 10,600, Midcap index extends losses; PSU banks gain

2018-05-21 moneycontrol
Buzzing: Shares of Indoco Remedies rose over 4 percent as USFDA has successfully completed the inspection at its manufacturing facilities.

 
Market Live: Sensex rebounds, Nifty above 10,600; Amara Raja, Century Textiles plunge

2018-05-21 moneycontrol
Pre-Opening Rate: Indostar Capital Finance share price settled at Rs 600 on the National Stock Exchange, up 4.9 percent compared to issue price of Rs 572.

 
Podcast | Sensex cracks 300 points ahead of Karnataka floor test; Nifty below 10,600

2018-05-18 moneycontrol
The S&P BSE Sensex cracked 300 points on Friday amid uncertainty as to who will form the government in Karnataka and rising crude oil prices. The Nifty50 slipped below its crucial support placed at 10,600 which does not augur well for the bulls.

 
Financials, higher crude pull Sensex down 301 pts, Nifty below 10,600; Bajaj Finance up 4%

2018-05-18 moneycontrol
Benchmark indices extended losses for fourth consecutive session on Thursday, weighed by banking & financials, metals, infra and oil stocks.

 
Closing Bell: Sensex down 301 pts, Nifty below 10,600; ICICI Bank, LT, Tata Motors dip 3%

2018-05-18 moneycontrol
Market Closing: Benchmark indices ended sharply lower, continuing weakness for the fourth consecutive session amid uncertainty over government formation in Karnataka, likely fiscal imbalance due to higher crude oil prices and weaker rupee.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 006162421